I'll take a crack at that. Background: On 9/26/2016 EAPH announced that they had received approval from the Mexican Government to sell women's health products (similar to Monistat in the US)in the country. This approval process took nearly one year to accomplish. They expect revenues to begin in Q12017. In the meantime they are nailing down contracts to actually sell the products. In addition they have hinted to a partnership with a international well known drug company.
I believe that the news coming end of this week early next week will be of the nature of those contracts that will represent actual sales numbers going forward. I do not think the "game changing" partnership with the major drug coming is what to expect with this upcoming release.
News 
Market Data 
Discover 
